Premium Company Profile - MGI Pharma

Publication Date	November 2007
Publisher	Datamonitor
Product Type	Report
Pages	56
ISBN Number	not applicable
Product Code	DAT08121

Price

£265.00
approximately: $395 | €316

PDF

PRINT £315 ($470 | €375)

Order above formats by FAX

Summary

Introduction

MGI Pharma's main focus is to develop and commercialize products for the treatment of diseases in the areas of oncology and acute care. The company has five marketed products, namely Aloxi, Dacogen, Gliadel Wafer, Salagen and Hexalen.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

The company's major contributor to revenue growth during 2002-2006 was product sales which increased at an absolute growth of +$311 million during the period.

MGI Pharma's biggest contributor to sales growth out to 2010 will be revenues from Dacogen and Aquavan sales.

In order to maximize the potential of its marketed products, the company implemented an extensive strategy to fully optimize the market potential for Aloxi by expanding its indication for the prevention of post operative nausea and vomiting (PONV).

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
- Summary
- Company Structure
- Company Overview And Key Facts
- Business Description
- History
- Locations And Subsidiaries
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Geographic Segment Performance
- Products & Services
- Marketed Products
- Pipeline Products
- Pipeline Products
- Historical Product Sales
- Ac Forecast Product Sales
- Competitors And Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- Swot Analysis
Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
Overview
- Discovery And Product Development
- Manufacturing
- Sales
- Scorecard
Overview
- Scorecard Analysis
- Key Employees
- List Of Key Employees
- Key Employee Biographies
- Financial And Operational Overview
- Financial And Operational Overview
Appendix
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
- Figure 1: Mgi Pharma - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Mgi Pharma - Key Strategic Revenues, 2002-2006 ($ Mn)
- Figure 3: Mgi Pharma - Key Strategic Revenues, 2006-2010 ($ Mn)
- Table 1: Mgi Pharma - Key Facts
- Table 2: Mgi Pharma - Locations And Subsidiaries
- Table 3: Mgi Pharma - Year-End Share Price And Market Capitalization, 2002-2006 ($)
- Table 4: Mgi Pharma - Key Events Impacting Share Price Performance
- Table 5: Mgi Pharma - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: Mgi Pharma - Operating Cost Ratio Analysis, 2002-2006 (% Of Total Revenues)
- Table 7: Mgi Pharma - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: Mgi Pharma - Cash Flow, 2002-2006 ($ Mn)
- Table 9: Mgi Pharma - Revenue Breakdown, 2002-2006 ($ Mn)
- Table 10: Mgi Pharma - Geographic Breakdown, 2002-2006 ($ Mn)
- Table 11: Mgi Pharma - Marketed Products
- Table 12: Mgi Pharma - In-House Pipeline Products
- Table 13: Mgi Pharma - Historical Product Sales, 2002-2006 ($ Mn)
- Table 14: Mgi Pharma - Forecast Sales, 2006-2010 ($ Mn)
- Table 15: Mgi Pharma - Key Suppliers
- Table 16: Mgi Pharma - Key Clients
- Table 17: Mgi Pharma - Key Shareholders
- Table 18: Mgi Pharma - Swot Analysis Summary
- Table 19: Mgi Pharma - Value Chain Analysis
- Table 20: Mgi Pharma - Scorecard
- Table 21: Mgi Pharma - Key Employees
- Table 22: Mgi Pharma - Financial And Operational Overview